Safety and immunogenicity of AS03(B) adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

Objectives To compare the safety, reactogenicity, and immunogenicity of an adjuvanted split virion H1N1 vaccine and a non-adjuvanted whole virion vaccine used in the pandemic immunisation programme in the United Kingdom. Design Open label, randomised, parallel group, phase II study. Setting Five UK...

Descripción completa

Detalles Bibliográficos
Autores principales: Waddington, Claire S, Walker, W T, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, P E, Allen, R J, Okike, I, Ladhani, S, Sheasby, E, Hoschler, K, Andrews, N, Waight, P, Collinson, A C, Heath, P T, Finn, A, Faust, S N, Snape, M D, Miller, E, Pollard, A J
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877808/
https://www.ncbi.nlm.nih.gov/pubmed/20508026
http://dx.doi.org/10.1136/bmj.c2649

Ejemplares similares

Ejemplares similares